73 customized services results for

Company IntroductionYour Trusted CDMO Partner Accelerating Biologics, Cell & Gene Therapies, and mRNA

tLVV) Delivery PathwayLeverage targeted lentiviral vectors (tLVV) for efficient and durable in vivo gene

The demand for viral vectors is rapidly increasing due to the recent growth of the gene therapy market

innovation capabilities in advanced therapies and reflects the accelerating global momentum of CAR-T and gene

expedited timeline, good Ab sequence diversity and better cost-effectiveness.Case Study: TIGIT RGA Reporter Gene

ProBio’s total cell and gene therapy solution covers CMC of plasmid and virus for IND filing as well

(Sample for Non-clinical Use)Lentiviral Vector (LVV) Packaging TestIn cell and gene therapy programs,

AAV Vector CDMO Services for Gene TherapyTriple Transient Transfection SystemCost-effective option for

With deep expertise in cell and gene therapy, ProBio delivers integrated, end to end solutions across

and service provider of life science R&D and manufacture, and ProBio, a leading CDMO in biologics and gene